Prestige Consumer Healthcare Inc. (PBH)
USD 78.79
(-1.99%)
USD 78.79
(-1.99%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 1.12 Billion USD | -0.21% |
| 2023 | 1.12 Billion USD | 3.76% |
| 2022 | 1.08 Billion USD | 15.21% |
| 2021 | 943.36 Million USD | -2.04% |
| 2020 | 963.01 Million USD | -1.31% |
| 2019 | 975.77 Million USD | -6.28% |
| 2018 | 1.04 Billion USD | 18.04% |
| 2017 | 882.06 Million USD | 9.4% |
| 2016 | 806.24 Million USD | 12.82% |
| 2015 | 714.62 Million USD | 18.73% |
| 2014 | 601.88 Million USD | -3.48% |
| 2013 | 623.59 Million USD | 41.38% |
| 2012 | 441.08 Million USD | 31.08% |
| 2011 | 336.51 Million USD | 11.42% |
| 2010 | 302.02 Million USD | -3.42% |
| 2009 | 312.71 Million USD | -4.25% |
| 2008 | 326.6 Million USD | 2.5% |
| 2007 | 318.63 Million USD | 7.4% |
| 2006 | 296.66 Million USD | -2.19% |
| 2005 | 303.31 Million USD | 244.99% |
| 2004 | 87.92 Million USD | 22.56% |
| 2003 | 71.73 Million USD | 55.09% |
| 2002 | 46.25 Million USD | 434.41% |
| 2001 | 8.65 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 282.74 Million USD | -1.25% |
| 2024 Q4 | 276.99 Million USD | -2.03% |
| 2024 FY | 1.12 Billion USD | -0.21% |
| 2024 Q1 | 279.3 Million USD | -2.29% |
| 2024 Q2 | 286.31 Million USD | 2.51% |
| 2023 Q2 | 289.27 Million USD | 4.41% |
| 2023 FY | 1.12 Billion USD | 3.76% |
| 2023 Q4 | 285.86 Million USD | 3.75% |
| 2023 Q3 | 275.52 Million USD | -4.75% |
| 2023 Q1 | 277.05 Million USD | 3.79% |
| 2022 Q3 | 274.47 Million USD | -0.64% |
| 2022 FY | 1.08 Billion USD | 15.21% |
| 2022 Q1 | 269.18 Million USD | 13.21% |
| 2022 Q2 | 276.22 Million USD | 2.62% |
| 2022 Q4 | 266.93 Million USD | -2.74% |
| 2021 Q2 | 237.42 Million USD | 3.5% |
| 2021 Q3 | 238.78 Million USD | 0.58% |
| 2021 Q1 | 229.39 Million USD | -8.69% |
| 2021 FY | 943.36 Million USD | -2.04% |
| 2021 Q4 | 237.76 Million USD | -0.43% |
| 2020 Q2 | 238.06 Million USD | 2.55% |
| 2020 Q4 | 251.23 Million USD | 4.01% |
| 2020 FY | 963.01 Million USD | -1.31% |
| 2020 Q1 | 232.15 Million USD | -3.68% |
| 2020 Q3 | 241.55 Million USD | 1.46% |
| 2019 Q4 | 241.02 Million USD | -0.16% |
| 2019 Q3 | 241.41 Million USD | 0.86% |
| 2019 Q2 | 239.35 Million USD | -5.76% |
| 2019 Q1 | 253.98 Million USD | -0.78% |
| 2019 FY | 975.77 Million USD | -6.28% |
| 2018 Q4 | 255.96 Million USD | -5.41% |
| 2018 FY | 1.04 Billion USD | 18.04% |
| 2018 Q1 | 256.57 Million USD | 6.61% |
| 2018 Q2 | 258.02 Million USD | 0.57% |
| 2018 Q3 | 270.61 Million USD | 4.88% |
| 2017 Q4 | 240.67 Million USD | 11.03% |
| 2017 FY | 882.06 Million USD | 9.4% |
| 2017 Q3 | 216.76 Million USD | 0.8% |
| 2017 Q2 | 215.05 Million USD | 2.61% |
| 2017 Q1 | 209.57 Million USD | 0.83% |
| 2016 Q2 | 206.06 Million USD | 7.25% |
| 2016 Q4 | 207.85 Million USD | 3.83% |
| 2016 Q3 | 200.19 Million USD | -2.85% |
| 2016 FY | 806.24 Million USD | 12.82% |
| 2016 Q1 | 192.13 Million USD | 1.1% |
| 2015 FY | 714.62 Million USD | 18.73% |
| 2015 Q3 | 197.6 Million USD | 9.01% |
| 2015 Q1 | 145.7 Million USD | 1.0% |
| 2015 Q2 | 181.26 Million USD | 24.41% |
| 2015 Q4 | 190.04 Million USD | -3.83% |
| 2014 Q2 | 168.44 Million USD | 17.82% |
| 2014 Q4 | 144.25 Million USD | -1.34% |
| 2014 Q3 | 146.21 Million USD | -13.2% |
| 2014 FY | 601.88 Million USD | -3.48% |
| 2014 Q1 | 142.97 Million USD | -7.47% |
| 2013 Q3 | 160.23 Million USD | -1.0% |
| 2013 FY | 623.59 Million USD | 41.38% |
| 2013 Q4 | 154.51 Million USD | -3.57% |
| 2013 Q2 | 161.85 Million USD | 10.11% |
| 2013 Q1 | 146.99 Million USD | 9.7% |
| 2012 Q4 | 133.99 Million USD | 26.11% |
| 2012 Q1 | 95.29 Million USD | -1.11% |
| 2012 Q2 | 105.54 Million USD | 10.76% |
| 2012 FY | 441.08 Million USD | 31.08% |
| 2012 Q3 | 106.25 Million USD | 0.67% |
| 2011 Q2 | 78.3 Million USD | 6.64% |
| 2011 Q1 | 73.42 Million USD | 2.86% |
| 2011 Q4 | 96.36 Million USD | 6.35% |
| 2011 Q3 | 90.6 Million USD | 15.71% |
| 2011 FY | 336.51 Million USD | 11.42% |
| 2010 Q2 | 84.18 Million USD | 14.96% |
| 2010 Q4 | 71.38 Million USD | -5.39% |
| 2010 FY | 302.02 Million USD | -3.42% |
| 2010 Q1 | 73.22 Million USD | 3.35% |
| 2010 Q3 | 75.44 Million USD | -10.37% |
| 2009 Q2 | 88.05 Million USD | 19.74% |
| 2009 Q3 | 80.27 Million USD | -8.83% |
| 2009 FY | 312.71 Million USD | -4.25% |
| 2009 Q4 | 70.85 Million USD | -11.74% |
| 2009 Q1 | 73.53 Million USD | -8.58% |
| 2008 Q4 | 80.43 Million USD | 0.26% |
| 2008 Q2 | 87.33 Million USD | 11.1% |
| 2008 Q3 | 80.22 Million USD | -8.15% |
| 2008 Q1 | 78.61 Million USD | 0.74% |
| 2008 FY | 326.6 Million USD | 2.5% |
| 2007 Q1 | 75.92 Million USD | -5.11% |
| 2007 Q2 | 84.55 Million USD | 11.36% |
| 2007 Q3 | 80.12 Million USD | -5.24% |
| 2007 Q4 | 78.03 Million USD | -2.61% |
| 2007 FY | 318.63 Million USD | 7.4% |
| 2006 Q1 | 63.55 Million USD | -18.89% |
| 2006 Q4 | 80.01 Million USD | 0.2% |
| 2006 Q2 | 73.34 Million USD | 15.4% |
| 2006 Q3 | 79.85 Million USD | 8.88% |
| 2006 FY | 296.66 Million USD | -2.19% |
| 2005 Q1 | 67.75 Million USD | 0.0% |
| 2005 Q2 | 81.34 Million USD | 20.06% |
| 2005 FY | 303.31 Million USD | 244.99% |
| 2005 Q3 | 75.85 Million USD | -6.75% |
| 2005 Q4 | 78.36 Million USD | 3.31% |
| 2004 FY | 87.92 Million USD | 22.56% |
| 2003 FY | 71.73 Million USD | 55.09% |
| 2002 FY | 46.25 Million USD | 434.41% |
| 2001 FY | 8.65 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cardinal Health, Inc. | 226.82 Billion USD | 99.504% |
| Cencora | 293.95 Billion USD | 99.617% |
| McKesson Corporation | 308.95 Billion USD | 99.636% |
| Owens & Minor, Inc. | 10.33 Billion USD | 89.11% |